Mode
Text Size
Log in / Sign up
N/A N=52 Randomized Treatment

Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS)

ARDS · Covid19 · Acute Hypoxemic Respiratory Failure

Enrolled (actual)
52
Serious AEs
0.0%
Results posted
Mar 2022
Primary outcome: Primary: Duration in Prone Position — 56.6; 45.7 hours

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Prolonged Proned Positioning (Other); Traditional Proning Arm (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Alabama at Birmingham
Primary completion
Mar 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Duration in Prone Position
56.6; 45.7
SECONDARY
Change in P:F Ratio
46.6; 44.3
SECONDARY
Change in Drive Pressure
0.16; 0.88
SECONDARY
Unplanned Extubations
0; 1
SECONDARY
Pressure Ulcers
1; 0
SECONDARY
Line Displacement
0; 1
SECONDARY
Vent Free Days
6.27; 5.81
SECONDARY
Mortality
14; 15
SECONDARY
Rescue Interventions
0; 1
SECONDARY
Tracheostomy
6; 3
SECONDARY
ICU Free Days
4.35; 4.15
SECONDARY
S:F Ratio
1.70; 1.69

Summary

Prone positioning is one of the few therapies known to improve mortality in ARDS. Traditionally, patients are proned for 16 hours per 24 hour period. Some retrospective data suggests improvement may persist beyond 16 hours. We aim to perform a pilot study comparing traditional prone positioning to prolonged prone positioning in patients with COVID-induced ARDS.

Eligibility Criteria

Inclusion Criteria

Positive COVID test Endotracheal Intubation P:F 48 hours prior to initiation of prone positioning Contraindication to proning Physician discretion

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04581811). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search